Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modelling the epidemiological and economic impact of digital adherence technologies with differentiated care for tuberculosis treatment in Ethiopia.
Goscé L, Tadesse AW, Foster N, van Kalmthout K, Rest JV, van der Wal J, Harker MJ, Madden N, Abdurhman T, Gadissa D, Bedru A, Dube TN, Alacapa J, Mganga A, Deyanova N, Charalambous S, Letta T, Jerene D, White R, Fielding KL, Houben RM, McQuaid CF. Goscé L, et al. Among authors: foster n. BMJ Glob Health. 2024 Dec 9;9(12):e016997. doi: 10.1136/bmjgh-2024-016997. BMJ Glob Health. 2024. PMID: 39653521 Free PMC article.
Digital adherence technology for TB: focus on livelihoods as well as lives.
McQuaid CF, Foster N, Quaife M, Levy J, Tadesse AW, Charalambous S, Alacapa JV, Deyanova N, Mganga A, Houben RMGJ, Fielding KL. McQuaid CF, et al. Among authors: foster n. Int J Tuberc Lung Dis. 2021 May 1;25(5):416-417. doi: 10.5588/ijtld.21.0070. Int J Tuberc Lung Dis. 2021. PMID: 33977914 No abstract available.
Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial.
Tadesse AW, Mohammed Z, Foster N, Quaife M, McQuaid CF, Levy J, van Kalmthout K, van Rest J, Jerene D, Abdurhman T, Yazew H, Umeta DG, Assefa D, Weldemichael GT, Bedru A, Letta T, Fielding KL. Tadesse AW, et al. Among authors: foster n. BMC Infect Dis. 2021 Nov 10;21(1):1149. doi: 10.1186/s12879-021-06833-x. BMC Infect Dis. 2021. PMID: 34758737 Free PMC article.
Evaluating the equity impact and cost-effectiveness of digital adherence technologies with differentiated care to support tuberculosis treatment adherence in Ethiopia: protocol and analysis plan for the health economics component of a cluster randomised trial.
Foster N, Tadesse AW, McQuaid CF, Gosce L, Abdurhman T, Assefa D, Bedru A, Houben RMGJ, van Kalmthout K, Letta T, Mohammed Z, van Rest J, Umeta DG, Weldemichael GT, Yazew H, Jerene D, Quaife M, Fielding KL. Foster N, et al. Trials. 2023 Apr 24;24(1):292. doi: 10.1186/s13063-023-07289-x. Trials. 2023. PMID: 37095533 Free PMC article.
Risk factors for poor engagement with a smart pillbox adherence intervention among persons on tuberculosis treatment in Ethiopia.
Tadesse AW, Cusinato M, Weldemichael GT, Abdurhman T, Assefa D, Yazew H, Gadissa D, Shiferaw A, Belachew M, Sahile M, van Rest J, Bedru A, Foster N, Jerene D, Fielding KL. Tadesse AW, et al. Among authors: foster n. BMC Public Health. 2023 Oct 14;23(1):2006. doi: 10.1186/s12889-023-16905-z. BMC Public Health. 2023. PMID: 37838677 Free PMC article.
Feasibility and acceptability of the smart pillbox and medication label with differentiated care to support person-centered tuberculosis care among ASCENT trial participants - A multicountry study.
Tadesse AW, Mganga A, Dube TN, Alacapa J, van Kalmthout K, Letta T, Mleoh L, Garfin AMC, Maraba N, Charalambous S, Foster N, Jerene D, Fielding KL. Tadesse AW, et al. Among authors: foster n. Front Public Health. 2024 Feb 20;12:1327971. doi: 10.3389/fpubh.2024.1327971. eCollection 2024. Front Public Health. 2024. PMID: 38444445 Free PMC article. Clinical Trial.
Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models.
Menzies NA, Gomez GB, Bozzani F, Chatterjee S, Foster N, Baena IG, Laurence YV, Qiang S, Siroka A, Sweeney S, Verguet S, Arinaminpathy N, Azman AS, Bendavid E, Chang ST, Cohen T, Denholm JT, Dowdy DW, Eckhoff PA, Goldhaber-Fiebert JD, Handel A, Huynh GH, Lalli M, Lin HH, Mandal S, McBryde ES, Pandey S, Salomon JA, Suen SC, Sumner T, Trauer JM, Wagner BG, Whalen CC, Wu CY, Boccia D, Chadha VK, Charalambous S, Chin DP, Churchyard G, Daniels C, Dewan P, Ditiu L, Eaton JW, Grant AD, Hippner P, Hosseini M, Mametja D, Pretorius C, Pillay Y, Rade K, Sahu S, Wang L, Houben RMGJ, Kimerling ME, White RG, Vassall A. Menzies NA, et al. Among authors: foster n. Lancet Glob Health. 2016 Nov;4(11):e816-e826. doi: 10.1016/S2214-109X(16)30265-0. Epub 2016 Oct 6. Lancet Glob Health. 2016. PMID: 27720689 Free PMC article.
1,360 results